Pee test could replace some painful bladder checks for cancer patients

NCT ID NCT07187063

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study is testing whether a simple urine test that looks for tumor DNA can help some bladder cancer patients safely have fewer cystoscopy exams. Cystoscopy involves inserting a camera into the bladder and can be uncomfortable. The trial will enroll 56 high-risk patients who have already completed initial treatment. Half will follow standard surveillance, while the other half will use the urine test to guide how often they need cystoscopy. The goal is to see if the urine test can reliably detect recurrences so that patients can avoid unnecessary procedures.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

UroAmp urine tumor DNA test

What this could lead to

If successful, this could allow some bladder cancer patients to have fewer invasive cystoscopy procedures while still catching recurrences early.

What could go wrong

This is a small, early-phase study with only 56 participants. The urine test may miss some recurrences, and results may not apply to all bladder cancer patients.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON MUSCLE INVASIVE BLADDER CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

non-invasive bladder urothelial carcinoma Non-Muscle Invasive Bladder Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Lahey Hospital and Medical Center

    RECRUITING

    Burlington, Massachusetts, 01805, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••